The global cold pain therapy market is projected to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of 4.6%. The increasing incidence of sports injuries and rising emphasis on exercise and gym activities, growing number of hip and knee surgeries across the globe, and growing need for safer pain management modalities as opposed to oral drug therapy are expected to drive the demand for cold pain therapy products during the study period. More
This report broadly segments the cold pain therapy market into product, application, and region.
On the basis of product, the market is categorized into OTC products and prescription products. In 2018, OTC products segment is expected to account for the largest share. The large share can be attributed to factors such as a high patient preference for topical pharmaceuticals compared to oral medications owing to its lower side effects, fast pain relief, and convenience in use. More